Newsletter Subscription

The European Commission and the US announce joint research efforts on rare diseases

Nov 4, 2010

The European Commission and the US National Institutes of Health (NIH) announced today at a high-level conference in Reykjavik in Iceland their intention to join forces on rare diseases research. The two institutions plan to coordinate their research funding on rare diseases and to make major investments in this research field in the years to come. The objective is to accelerate medical breakthroughs for people affected by rare diseases – which is the case for 6 to 8 % of the EU population. The European Commission also announced that it will earmark in 2011 more than €100 million for research and innovation on rare diseases, including clinical trials of promising treatments already stemming from European research. This will be the largest single investment in this research field done by the European Commission.(Source: European Commission)



BILAT-USA (Grant Agreement no: 244434) and Link2US (Grant Agreement no: 244371) Projects are co-funded by the European Union’s Capacities Programme on International Cooperation under the 7th Framework Programme for Research and Technological Cooperation.